O-glycoside biomarker of apolipoprotein C3: Responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft VS host disease

Journal of Proteome Research

Volumn 8, Issue 2, 2009, Pages 603-612

  Harvey, Stephen B ^a   Zhang, Yan ^a   Wilson Grady, Joshua ^a   Monkkonen, Teresa ^a   Nelsestuen, Gary L ^a,f   Kasthuri, Raj S ^b,c   Verneris, Michael R ^b   Lund, Troy C ^c   Ely, E Wesley ^d   Bernard, Gordon R ^d   Zeisler, Harald ^e   Homoncik, Monika ^e   Jilma, Bernd ^e   Swan, Therese ^b   Kellogg, Todd A ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c University of North carolonia   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f NONE   (United States)

Author keywords

Bariatric surgery; Glycomic isoform biomarkers; Hepatitis C; Liver cirrhosis; Obesity; Sepsis; Umbilical cord blood transplant

Indexed keywords

ANTIVIRUS AGENT; APOLIPOPROTEIN C3; BIOLOGICAL MARKER; GLYCOSIDE; INTERFERON; METFORMIN;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BARIATRIC SURGERY; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HELLP SYNDROME; HEPATITIS C; HUMAN; LIVER INJURY; MALE; MORTALITY; OBESITY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN LOCALIZATION; SEPSIS; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

ADULT; AGED; APOLIPOPROTEIN C-III; BARIATRIC SURGERY; BIOLOGICAL MARKERS; DIABETES MELLITUS; FEMALE; GLYCOSIDES; GRAFT VS HOST DISEASE; HUMANS; HYPOGLYCEMIC AGENTS; LIVER DISEASES; MALE; METFORMIN; MIDDLE AGED; OBESITY; PREGNANCY; PROTEIN ISOFORMS; SEPSIS;

HEPATITIS C VIRUS;

EID: 61849158775     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800751x     Document Type: Article

References (46)

1. Zolg, W. The proteomic search for diagnostic biomarkers: lost in translation? Mol. Cell. Proteomics 2006, 5 (10), 1720-6.
2. Qiu, Y.; Patwa, T. H.; Xu, L.; Shedden, K.; Misek, D. E.; Tuck, M.; Jin, G.; Ruffin, M. T.; Turgeon, D. K.; Synal, S.; Bresalier, R.; Marcon, N.; Brenner, D. E.; Lubman, D. M. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J. Proteome Res. 2008, 7 (4), 1693-703.
3. Zhao, J.; Patwa, T. H.; Qiu, W.; Shedden, K.; Hinderer, R.; Misek, D. E.; Anderson, M. A.; Simeone, D. M.; Lubman, D. M. Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera. J. Proteome Res. 2007, 6 (5), 1864-74.
4. Zhao, J.; Qiu, W.; Simeone, D. M.; Lubman, D. M. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. J. Proteome Res. 2007, 6 (3), 1126-38.
5. Zhao, J.; Simeone, D. M.; Heidt, D.; Anderson, M. A.; Lubman, D. M. Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum. J. Proteome Res. 2006, 5 (7), 1792-802.
6. Kirmiz, C.; Li, B.; An, H. J.; Clowers, B. H.; Chew, H. K.; Lam, K. S.; Ferrige, A.; Alecio, R.; Borowsky, A. D.; Sulaimon, S.; Lebrilla, C. B.; Miyamoto, S. A serum glycomics approach to breast cancer biomarkers. Mol. Cell. Proteomics 2007, 6 (1), 43-55.
7. Kyselova, Z.; Mechref, Y.; Al Bataineh, M. M.; Dobrolecki, L. E.; Hickey, R. J.; Vinson, J.; Sweeney, C. J.; Novotny, M. V. Alterations in the serum glycome due to metastatic prostate cancer. J. Proteome Res. 2007, 6 (5), 1822-32.
8. Leiserowitz, G. S.; Lebrilla, C.; Miyamoto, S.; An, H. J.; Duong, H.; Kirmiz, C.; Li, B.; Liu, H.; Lam, K. S. Glycomics analysis of serum: a potential new biomarker for ovarian cancer? Int. J. Gynecol. Cancer 2008, 18 (3), 470-5.
9. Saldova, R.; Royle, L.; Radcliffe, C. M.; Abd Hamid, U. M.; Evans, R.; Arnold, J. N.; Banks, R. E.; Hutson, R.; Harvey, D. J.; Antrobus, R.; Petrescu, S. M.; Dwek, R. A.; Rudd, P. M. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 2007, 1712, 1344-56.
10. Desmyter, L.; Fan, Y. D.; Praet, M.; Jaworski, T.; Vervecken, W.; De Hemptinne, B.; Contreras, R.; Chen, C. Rating of CC1(4)-induced rat liver fibrosis by blood serum glycomics. J. Gastroenterol. Hepatol. 2007, 22 (7), 1148-54.
11. Patwa, T. H.; Zhao, J.; Anderson, M. A.; Simeone, D. M.; Lubman, D. M. Screening of glycosylation patterns in serum using natural glycoprotein microarrays and multi-lectin fluorescence detection. Anal. Chem. 2006, 78 (18), 6411-21.
12. Atwood, J. A., 3rd; Cheng, L.; Alvarez-Manilla, G.; Warren, N. L.; York, W. S.; Orlando, R. Quantitation by isobaric labeling: applications to glycomics. J. Proteome Res. 2008, 7 (1), 367-74.
13. Kim, Y. G.; Jang, K. S.; Joo, H. S.; Kim, H. K.; Lee, C. S.; Kim, B. G. Simultaneous profiling of N-glycans and proteins from human serum using a parallel-column system directly coupled to mass spectrometry. J. Chromatogr., B 2007, 850 (1-2), 109-19.
14. Kita, Y.; Miura, Y.; Furukawa, J.; Nakano, M.; Shinohara, Y.; Ohno, M.; Takimoto, A.; Nishimura, S. Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N-glycans. Mol. Cell. Proteomics 2007, 6 (8), 1437-45.
15. Miura, Y.; Hato, M.; Shinohara, Y.; Kuramoto, H.; Furukawa, J.; Kurogochi, M.; Shimaoka, H.; Tada, M.; Nakanishi, K.; Ozaki, M.; Todo, S.; Nishimura, S. BlotGlycoABCTM, an integrated glycob-lotting technique for rapid and large scale clinical glycomics. Mol. Cell. Proteomics 2008, 7(2), 370-7.
16. Zhuang, Z.; Starkey, J. A.; Mechref, Y.; Novotny, M. V.; Jacobson, S. C. Electrophoretic analysis of N-glycans on microfluidic devices. Anal. Chem. 2007, 79 (18), 7170-5.
17. Wada, Y.; Azadi, P.; Costello, C. E.; Dell, A.; Dwek, R. A.; Geyer, H.; Geyer, R.; Kakehi, K.; Karlsson, N. G.; Kato, K.; Kawasaki, N.; Khoo, K. H.; Kim, S.; Kondo, A.; Lattova, E.; Mechref, Y.; Miyoshi, E.; Nakamura, K.; Narimatsu, H.; Novotny, M. V.; Packer, N. H.; Perreault, H.; Peter-Katalinic, J.; Pohlentz, G.; Reinhold, V. N.; Rudd, P. M.; Suzuki, A.; Taniguchi, N. Comparison of the methods for profiling glycoprotein glycans - HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology 2007, 17(4), 411-22.
18. Bergen, H. R.; Lacey, J. M.; O'brien, J. F.; Naylor, S. Online single-step analysis of blood proteins: the transferrin story. Anal. Biochem. 2001, 296 (1), 122-9.
19. Lacey, J. M.; Bergen, H. R.; Magera, M. J.; Naylor, S.; O'brien, J. F. Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry. Clin. Chem. 2001, 47 (3), 513-8.
20. Sanz-Nebot, V.; Balaguer, E.; Benavente, F.; Neususs, C.; Barbosa, J. Characterization of transferrin glycoforms in human serum by CE-UV and CE-ESI-MS. Electrophoresis 2007, 28 (12), 1949-57.
21. Nelsestuen, G. L.; Zhang, Y.; Martinez, M. B.; Key, N. S.; Jilma, B.; Verneris, M.; Sinaiko, A.; Kasthuri, R. S. Plasma protein profiling: unique and stable features of individuals. Proteomics 2005, 5 (15), 4012-24.
22. Bondarenko, P. V.; Cockrill, S. L.; Watkins, L. K.; Cruzado, I. D.; Macfarlane, R. D. Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. J. Lipid Res. 1999, 40 (3), 543-55.
23. Atger, V.; Beyne, P.; Frommherz, K.; Roullet, J. B.; Drueke, T. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins. Ann. Biol. Clin. (Paris) 1989, 47 (8), 497-501.
24. Harake, B.; Caines, P. S.; Thibert, R. J.; Cheung, R. M. A simple micromethod for rapid assessment of the distribution of apolipo-protein C isoforms in very-low-density lipoprotein. Clin. Biochem. 1991, 24 (3), 255-60.
25. Alborn, W. E.; Prince, M. J.; Konrad, R. J. Relationship of apolipo-protein A5 and apolipoprotein C3 levels to serum triglycerides in patients with type 2 diabetes. Clin. Chim. Acta 2007, 378 (1-2), 154-8.
26. Gervaise, N.; Garrigue, M. A.; Lasfargues, G.; Lecomte, P. Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes. Diabetologia 2000, 43 (6), 703-8.
27. Huff, M. W.; Nestel, P. J. Metabolism of apolipoproteins CII, CIII1, CIII2 and VLDL-B in human subjects consuming high carbohydrate diets. Metabolism 1982, 31 (5), 493-8.
28. Mauger, J. F.; Couture, P.; Bergeron, N.; Lamarche, B. Apolipoprotein C-III isoforms: kinetics and relative implication in lipid metabolism. J. Lipid Res. 2006, 47 (6), 1212-8.
29. Homoncik, M.; Sieghart, W.; Formann, E.; Schmid, M.; Ferenci, P.; Gangl, A.; Jilma, B.; Peck-Radosavljevic, M. Erythropoietin treatment is associated with more severe thrombocytopenia in patients with chronic hepatitis C undergoing antiviral therapy. Am. J. Gastroenterol. 2006, 101 (10), 2275-82.
30. Homoncik, M.; Jilma-Stohlawetz, P.; Schmid, M.; Ferlitsch, A.; Peck-Radosavljevic, M. Erythropoietin increases platelet reactivity and platelet counts in patients with alcoholic liver cirrhosis: a randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther 2004, 20 (4), 437-13.
31. Stone, J. H. HELLP syndrome: hemolysis, elevated liver enzymes, and low platelets. JAMA 1998, 280 (6), 559-62.
32. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am. J. Obstet. Gynecol. 2000, 183 (1), S1-S22.
33. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int. J. Gynaecol. Obstet., 2002, 77 (1), 67-75.
34. Knaus, W. A.; Draper, E. A.; Wagner, D. P.; Zimmerman, J. E. APACHE II: a severity of disease classification system. Crit. Care Med. 1985, 13 (10), 818-29.
35. Barker, J. N.; Weisdorf, D. J.; Defer, T. E.; Blazar, B. R.; Mcglave, P. B.; Miller, J. S.; Verfaillie, C. M.; Wagner, J. E. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005, 105 (3), 1343-7.
36. Brunstein, C. G.; Barker, J. N.; Weisdorf, D. J.; Defer, T. E.; Miller, J. S.; Blazar, B. R.; Mcglave, P. B.; Wagner, J. E. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007, 110 (8), 3064-70.
37. Chan, D. C.; Watts, G. F. Apolipoproteins as markers and managers of coronary risk. QJM 2006, 99 (5), 277-87.
38. Chan, D. C.; Watts, G. F.; Nguyen, M. N.; Barrett, P. H. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Arterioscler. Thromb. Vasc. Biol. 2006, 26 (3), 590-6.
39. Pemberton, P. W.; Smith, A.; Warnes, T. W. Non-invasive monitoring of oxidant stress in alcoholic liver disease. Scand. J. Gastroenterol. 2005, 40 (9), 1102-8.
40. Nelsestuen, G. L.; Harvey, S. B.; Zhang, Y.; Kasthuri, R. S.; Sinaiko, A. R.; Ely, E. W.; Bernard, G. R.; Homoncik, M.; Jilma, B. Top-down proteomic analysis by MALDI-TOF profiling: concentration-independent biomarkers Proteomics-Clinical. Applications 2008, 2, 158-166.
41. Kasthuri, R. S.; Verneris, M. R.; Ibrahim, H. N.; Jilma, B.; Nelsestuen, G. L. Studying multiple protein profiles over time to assess biomarker validity. Expert Rev Proteomics 2006, 3 (4), 455-64.
42. Salpeter, S. R. A Systematic review of metformin treatment in persons at risk for diabetes mellitus. Diabetes, 2008 (July), www-.cardiologyreviewonline.com.
43. Guidone, C.; Manco, M.; Valera-Mora, E.; Iaconelli, A.; Gniuli, D.; Mari, A.; Nanni, G.; Castagneto, M.; Calvani, M.; Mingrone, G. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006, 55 (7), 2025-31.
44. Parkes, J.; Guha, I. N.; Roderick, P.; Rosenberg, W. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J. Hepatol. 2006, 44 (3), 462-74.
45. Vaith, P.; Assmann, G.; Uhlenbruck, G. Characterization of the oligosaccharide side chain of apolipoprotein C-III from human plasma very low density lipoproteins. Biochim. Biophys. Acta 1978, 541 (2), 234-40.
46. Levent, G.; Ali, A.; Ahmet, A.; Polat, E. C.; Aytac, C.; Ayse, E.; Ahmet, S. Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy. J. Transl. Med. 2006, 4, 25.